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Abstract
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Objectives Acute pain management in opioid users can be challenging in the perioperative period. This study focuses on whether use of opioids increases sedation medication requirements in patients undergoing port placement under moderate sedation.
Materials and Methods A retrospective review was performed on all patients undergoing port placement between June 1, 2017, and June 30, 2019. Exclusion criteria
included receiving general anesthesia, no sedation, and errors in data entry. Data
collection included demographics, use of opioids, benzodiazepines, antidepressants,
tobacco, alcohol, and sedation data.
Results Opioid, benzodiazepine, and selective serotonin reuptake inhibitors
(SSRIs)/serotonin-norepinephrine reuptake inhibitors (SNRIs) use was significantly
associated with higher sedation drug dose requirements. Patients using opioids
required 10.5% higher doses of midazolam compared with nonusers. Benzodiazepine
users required 16.3% additional dosage of midazolam than nonusers. Finally, patients
on SSRIs/SNRIs medications required 11.8% higher midazolam dosing when compared
with nonusers.
Conclusion Anticipating higher needs of sedation medications during procedures in
patients with history of psychotropic agents use can allow for more effective sedation
and patient satisfaction. More patient and provider awareness is needed on this topic,
as health care policy is moving toward value-based healthcare, with patient satisfaction surveys being one of its indicators.

Introduction
Opioids are often used perioperatively–short term in acute
postprocedure period or long term in patients with cancer
related pain or palliative care.1 In the past several decades,
there has been an increase in opioid use for chronic noncancer-related pain; this trend has only recently started to
decrease with improved utilization of nonopioid, nonpharmacologic interventions, and implementation of clinical
DOI https://doi.org/
10.1055/s-0041-1729469
ISSN 2457-0214

guidelines in using opioids.1-4 Overall opioid prescriptions
have increased from 2006 and peaked in 2012 at more than
255 million dispensed prescriptions. It downtrended from
2012 with 168 million prescriptions dispensed in 2018.5
With use of opioids, there is concern for tachyphylaxis, dependence, opioid-induced hyperalgesia, and even opioid-related
respiratory depression and death.6,7 Opioid tolerance, as
defined by FDA, occurs when an individual takes ≥1 week of
the following agents and doses: 30 mg oral oxycodone/day,
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25 mcg transdermal fentanyl/hour, 60 mg oral morphine/day,
or an equivalent dose of a different opioid.8 Therefore, even
short courses of opioids can result in tolerance with patients
requiring higher doses to achieve similar analgesic effect.7
This pattern has been seen in patients taking opioids for both
cancer and noncancer-related pain.9
Pain management during perioperative period can
be challenging in patients who have history of prescription opioid use, opioid misuse, or even those on opioid
agonist/antagonist regimens for withdrawal and cessation.6
Different levels of sedation ranging from minimal sedation
to general anesthesia need to be performed, based on procedure type to provide adequate sedation and analgesia during
procedures.6,10 Moderate sedation is used frequently for
minimally invasive procedures including endoscopies, bronchoscopies, port placements, central line placements, percutaneous biopsies (i.e., liver, kidney, lung), and drain placements,
etc.10-12 Benzodiazepines and opioids are used during moderate sedation, wherein patients are easily arousable to verbal
and tactile stimuli and are able to protect their airway and
maintain spontaneous ventilation.10 Benzodiazepines and
opioids have several therapeutic effects, and the anxiolytic
effects of benzodiazepines allows for decreased perception
of pain by working synergistically with opioid and nonopioid analgesic medications.10,13,14 Adequate sedation allows for
timely and ease in procedure completion while minimizing
patient discomfort.10
Higher sedation requirements in patients with history
of opioid and alcohol use disorders has been documented
during colonoscopies and mechanical ventilation.11,15 Other
factors contributing to higher sedation requirements include
anxiety, agitation, and pre-existing high pain sensitivity;
some of these patients even have a history of concomitant
use of benzodiazepines and antidepressants.11,16
The purpose of this study is to evaluate whether use of
opioids would increase sedation medication requirements
in patients undergoing minimally invasive procedures under
moderate sedation at a single tertiary care center. We elected
central venous port placement as an index minimally invasive procedure to decrease procedural heterogeneity.

Materials and Methods
Patient Selection and Data Collection

Following approval from local Institutional Review Board, a
retrospective study was performed on all the patients who
had port placement between June 1, 2017, and June 30,
2019 at a single tertiary care center. Informed consent was
obtained from all patients included in the study prior to performing procedure and data collection. A total of 430 different
instances of port placement occurred during this time
period. Patients with known history of illicit opioid use and
patients who had no sedation or required general anesthesia
were excluded from the current study. In addition, cases with
errors in data entry at time of procedure were also excluded.
Based on these criteria, a total of 27 cases were excluded.
For the remaining 403 patients, electronic medical records were reviewed for following data collection:
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patient demographics, use of tobacco, alcohol use, and sedation data (amounts of midazolam, fentanyl, and diphenhydramine). A procedural nurse administered moderate sedation
medications during port placement and a pain scale (1–10)
goal of < 4 was used as the target for adequate sedation.
All the providers had at least 3 years of postinterventional
radiology fellowship experience. The following definitions
were used for opioids and other psychotropic substances.
Use of opioids was defined as prescribed opioids for ≥ 1 week
within the last 3 years prior to port placement. Additional
data collected included use of benzodiazepines (defined as
current or history of use of benzodiazepine products for at
least 7 days within 5 years prior to date of port placement),
use of typical antidepressants (defined as current or history
of use of selective serotonin reuptake inhibitors [SSRIs] and
serotonin-norepinephrine reuptake inhibitors [SNRIs] for at
least 7 days within 5 years prior to date of port placement),
and any documented history of use of pregabalin/gabapentin.

Statistical Analysis

Statistical analysis was performed using SAS software
version 9.4 (SAS Institute Inc., Cary, NC, USA). t-tests were
used to identify average doses of midazolam and fentanyl
used in patients with use of opioids and other psychotropic
substances including benzodiazepines, gabapentin/pregabalin, and antidepressants. Overall mean, standard deviations,
and p values were calculated using SAS software. Significance
was indicated by a p value of ≤ 0.05.

Results
Of the 403 remaining port placements, the following were
the patient demographics: 44% were male, 92% Caucasian, 7%
African-American and 1% Asian; 18% had history of alcohol
abuse and 53% had history of tobacco use. Of the 403 cases,
185/403 (46%) had used opioids for at least 1 week in the
3 years prior to port placement, 81/403 (20%) had used benzodiazepines for at least 1 week in the 5 years prior to port
placement, 81/403 (20%) of the patients had used antidepressants for at least 7 days in the 5 years prior to port placement,
and 44/403 (11%) had used gabapentin/pregabalin.
Statistical analysis was performed using SAS software. Patients who were opioid users needed 10.5% significantly higher doses of midazolam when compared
with nonusers (p value = 0.04), and these patients also
required 7.9% higher doses of fentanyl compared with nonusers; however, the latter results were not statistically significant
(p value = 0.09). Patients who had history of use of benzodiazepines required 11.3% significantly higher doses of fentanyl and 16.3% significantly higher doses of midazolam
when compared with nonusers (p value = 0.05 and 0.01,
respectively). Finally, patients with history of antidepressant
use required 11.9% significantly higher doses of midazolam
and 7.8% higher doses of fentanyl when compared with nonusers, however, the latter was not statistically significant
(p values 0.05 and 0.17, respectively). Patients who were
users of pregabalin/gabapentin required higher doses of
fentanyl and midazolam when compared with nonusers;
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Table 1 Demonstrates the average midazolam and fentanyl doses required in patients with use of opioids and other psychotropic
agents
Psychotropic medication class

Midazolam (mg)

p value

Fentanyl (mcg)

0.04

Opioids:

Users:

2.7 ± 1.3

Nonusers:

2.5 ± 1.1

123 ± 60
114 ± 48
0.01

Benzodiazepines:

0.05

Users:

2.9 ± 1.4

129 ± 54

Nonusers:

2.5 ± 1.6

116 ± 54
0.05

Antidepressants:

0.17

Users:

2.8 ± 1.2

126 ± 52

Nonusers:

2.5 ± 1.2

117 ± 54

Pregabalin/gabapentin:

p value
0.09

0.81

0.62

Users:

2.6 ± 1.5

122 ± 63

Nonusers:

2.6 ± 1.2

118 ± 53

p values obtained by performing t-tests through SAS software are also represented in this table.

however, these results were not statistically significant.
►Table 1 demonstrates average dose of midazolam and fentanyl with associated standard deviations and p values in
patients with use of opioids and other psychotropic agents.

Discussion
After heart disease, cancer is the most common cause of
death with an estimated approximately 600,000 deaths
expected in 2020.17 However, given advances in treatment,
earlier detection of disease, improvement in screening
modalities, and decrease in risk factors such as smoking,
cancer death continues to decrease. This has resulted in
greater number of cancer survivors, thus resulting in a
greater number of patients managing cancer-related pain on
a day-to-day basis.9,17 Opioids continue to be one of the primary mainstays in treatment of severe cancer-related pain
when nonopioid interventions have failed or to augment
these interventions for breakthrough pain. In addition, there
has been an overall increase in prescription of benzodiazepines over the past several decades. One study reported
a 67% increase in number of individuals filling benzodiazepine prescriptions from 1996 to 2013.18 During the same
time period, the study noted three times increase in the
quantity of benzodiazepines filled due to increase in dosage,
number of prescriptions, duration of prescriptions, or a combination of these factors.18
Tachyphylaxis, physical dependence, opioid-induced
hyperalgesia, addiction, and overdose continue to be concerning factors with use of opioids. A single dose may be sufficient
to develop tolerance for some opioid effects; however, in most
cases, development of tolerance depends on duration, dose,
and type of opioid utilized.3 Tolerance to effects of analgesia and
euphoria occur earlier than effects of respiratory depression;
thus, the increasing concern for overdose when dose escalation occurs.3 It is believed that dose escalation up to 10 times
initial dose may be required for similar analgesic effects.3
Journal of Clinical Interventional Radiology ISVIR

However, following cessation of opioid use, effects of tolerance and dependence resolve within days to weeks, depending on strength, duration and type of opioid used.3
Various studies have looked at sedation in patients
with history of substance use disorders in various settings
including endoscopies, mechanically ventilated patients,
and dental procedures.11,15,19 Patel et al demonstrated that
during sedation for colonoscopies, opioid users require significantly higher doses of fentanyl (by 23%) and midazolam
(by 24%) compared with patients with alcohol use and
control groups.11 This is consistent with findings from this
current study, and it demonstrates significantly increased
requirement of midazolam by 10.5% in patients who are
opioid users in comparison to nonusers during port placement. These patients also had required 7.9% increase in fentanyl dosing; however, these results were not significant at
the 95% confidence interval. Another study demonstrated
that during mechanical ventilation in intensive care unit,
patients with alcohol use disorder needed greater amounts
of sedatives and opioids to achieve similar degree of sedation than their nonalcoholic counterparts.15 Cook et al also
demonstrated that greater amounts of diazepam are required
to achieve similar levels of sedation in patients using alcohol
and benzodiazepines even at low doses when these patients
are undergoing elective dental and endoscopic procedures.19
These results are similar to the current study. Patients who
had history of benzodiazepine use required 11.3% significantly higher doses of fentanyl and 16.3% significantly
higher doses of midazolam when compared with nonusers.
Tolerance has been attributed to increased requirements
of sedatives in patients with history of benzodiazepine
use.19,20 Sedative and hypnotic effects of benzodiazepines
develop tolerance earlier as compared with other therapeutic
effects of benzodiazepines, and tolerance occurs much faster
with shorter half-life agents.20,21 However, benzodiazepines
appear to have continued efficacy against anxiolysis even
with long-term use, and some studies have attributed this as
Vol. 00
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reason for lack of dose escalation in chronic benzodiazepine
users.20,22 Overall, both opioids and benzodiazepines augment each other’s effects during sedation, and the increase in
dose requirements during perioperative period is likely due
to tolerance exhibited to both agents.10,11,20
To our knowledge, this is the first study that demonstrated
not only increased midazolam requirements in patients with
history of prescription benzodiazepine use, but also significantly increased midazolam requirements in patients with
history of prescription antidepressant use (SSRIs and SNRIs)
in patients undergoing port placement. In addition, these
patients also required increased doses of fentanyl during port
placement when compared with non-users, however, these
results were not significant at the 95% confidence interval.
The exact mechanism through which antidepressant users
require higher benzodiazepines is unclear. However, it is likely
multifactorial, with a combination of biochemical changes
and variable neurotransmitter availability in the central nervous system (CNS) caused by multiple psychotropic medications and presence of somatic and psychological factors
during the perioperative period.23-25 In our study, anxiety and
mood changes during the procedure likely potentiate pain
perception, which subsequently results in higher midazolam
and fentanyl doses in patients with history of prescription
antidepressant use. Patients with preoperative depression
and anxiety reported having greater amounts of postoperative pain and resultant increase in opioid use.25,26 One study
performed psychological assessment (that included patient
health questionnaire among other questionnaires) in all
patients prior to oropharyngeal surgery. The study indicated
that significantly more opioids were needed for higher postoperative pain which, in turn, was correlated to psychological anticipation of higher pain and/or with higher degree of
clinical depression.25 Although these studies looked at postoperative pain, similar rationale can be extrapolated to the
intraoperative period.
To our knowledge, this is the first study that has looked
at increased sedation requirements during a discrete minimally invasive procedure performed under moderate sedation in patients with known history of prescription opioid
use. Central venous ports were chosen as an ideal index procedure to limit procedural heterogeneity such as anatomical
location, procedural duration, and procedure -related pain.
Port placement is a relatively standardized procedure that is
short in duration, involves minimal intraprocedural discomfort, and has little to no postprocedural pain.
Approximately, 1.8 million new cases of cancer are
expected to be diagnosed in 2020 in United States, a significant portion of whom will require central venous access
devices (i.e., port) for infusion of chemotherapy.17 Therefore,
identifying patients who have been on opioids for ≥ 1 week
can allow interventionalists to provide optimal preprocedural sedation planning.
This study does have some limitations. It is a retrospective study at a single institution, and data was collected on
a single procedure type (port placement). Additional limitations include variable strengths and durations of use of
opioids and other psychotropic agents (ranging from 1 week
Journal of Clinical Interventional Radiology ISVIR
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to several months). Also, patient-reported pain scores can
be highly subjective and would be difficult to account for.
Furthermore, nurses and/or physicians were not blinded to
patient’s medical history of opioid and/or psychotropic use,
potentially introducing an element of bias.

Conclusion
Patients with history of opioid use require significantly
higher sedation drug doses compared with nonusers, and
similar trends can be seen in patients with history of use of
benzodiazepines and antidepressants. Anticipating higher
requirements of these medications in these patients can
allow planning for other alternatives for analgesia/anesthesia, increase patient satisfaction, and allow timely completion of minimally invasive procedures performed under
moderate sedation. More patient and provider awareness are
needed on this topic, as health care policy has been moving
more and more toward value-based health care, with patient
satisfaction surveys being one of its indicators.
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